Acknowledgements We thank the University of Maryland Electron Microscopy Core Imaging Facility for transmission electron microscopy consultation and training, Nagendra Yadava and Brandon Carter-Cooper at the University of Maryland Translational Laboratory Shared Service for respirometry consultation, the Ndufa1 antibody, and recombinant perfringolysin O, Amanda Law for shared equipment, Victoria Meadows, Jessica Fluharty, Henry Haller, Erin Weinhold, and Peter Moon for technical assistance, and Scott Thompson for editorial feedback
0.16 ng/ml/12 ml/day till the sacrifice) and intragastrically after cuprizone instilations, while controls received simultaneously drinking water only (12 ml/day) as well as an equivolume of saline (5 ml/kg) intragastrically after cuprizone instillations
Individual absorption and lifestyle factors also affect how quickly results develop
twice-daily injections typical for injectable protocols No refrigeration needed (capsules stable at room temperature) Convenient for travel and busy schedules Dietary supplement status (no prescription required) Injectable Characteristics: Potentially higher bioavailability reaching systemic circulation (comparative human data does not exist) Established user base with extensive anecdotal reports Ability to perform local injection near injury sites Dosing protocols from practitioner guidance more available Consideration: Oral BPC-157 suits needle-averse beginners prioritizing convenience
Worth the money I think everyone should try this brand
